Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
Manufacturing & innovation
Manufacturing Capabilities
Every dosage form we make
Manufacturing Capabilities
Manufacturing Network
Plants & 20 workshops
Manufacturing Network
Research & Development
Labs, ATMP & formulation
Research & Development
Quality & GMP
Standards & traceability
Quality & GMP
Alliance Stem Cell Centre
Stem-cell, NK & exosome science
Alliance Stem Cell Centre
Integrated Value Chain
Farm → chemicals → finished
Integrated Value Chain
What we make
Every major dosage form, made to one GMP standard
Explore capabilities
Explore capabilities
ALIREPOTINIB
Rx
Cancer & Blood Disorders

ALIREPOTINIB

Repotrectinib
Generic (INN)
Repotrectinib
Strength
40mg
Packaging
60 capsules/bottle
Indication
Targeted treatment for ROS1-positive lung cancer and NTRK-fusion cancers. (See package insert.)
Registration No.
09 L 1388/25
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
ALIPONATIB 45mg
ALIPONATIB 45mg
Ponatinib
ALIENTRECTINIB
ALIENTRECTINIB
Entrectinib
LORLATINIB 100mg
LORLATINIB 100mg
Lorlatinib
OSIMITIB
OSIMITIB
Osimertinib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文